https://www.zacks.com/stock/news/2210749/are-investors-undervaluing-cardinal-health-cah-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2210749
Jan 16, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:-331818751490698802
0
https://www.zacks.com/stock/news/2214297/5-low-leverage-stocks-to-buy-on-expectations-of-rate-cuts?cid=CS-ZC-FT-analyst_blog|rw-2214297
Jan 23, 2024 - The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy NSIT, ACA, CAH, PLAB and WING.
zc:-7136558593857641543
0
https://www.zacks.com/stock/news/2217006/ahead-of-cardinal-cah-q2-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2217006
Jan 29, 2024 - Get a deeper insight into the potential performance of Cardinal (CAH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:-3454865207968804765
0
https://www.zacks.com/stock/news/2218722/medical-device-stocks-earnings-on-feb-1-rvty-cah-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2218722
Jan 31, 2024 - Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
zc:-2777613108129733837
0
https://www.zacks.com/stock/news/2218740/are-medical-stocks-lagging-cardinal-health-cah-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2218740
Jan 31, 2024 - Here is how Cardinal Health (CAH) and CSL Limited Sponsored ADR (CSLLY) have performed compared to their sector so far this year.
zc:8264123481735934851
0
https://www.zacks.com/stock/news/2219544/cardinal-health-cah-beats-on-q2-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2219544
Feb 01, 2024 - Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
zc:461947116294527123
0
https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054
Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance
zc:2026466960322006956
0
https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766
Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
zc:1313567782092185077
0
https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631
Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
zc:-6790523995716162957
0
https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769
Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
zc:-7241614452320905990
0